FDA Approves Treatment for Chronic Kidney Disease ...Middle East

PR Newswire - News
FDA Approves Treatment for Chronic Kidney Disease
SILVER SPRING, Md., April 30, 2021 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney function decline, kidney failure, cardiovascular death and hospitalization for heart failure in adults with chronic...

Hence then, the article about fda approves treatment for chronic kidney disease was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Treatment for Chronic Kidney Disease )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News